Stockreport

Glaukos Stock Down Despite NDA Submission of Epioxa to the FDA [Yahoo! Finance]

Glaukos Corporation  (GKOS) 
Last glaukos corporation earnings: 2/27 04:15 pm Check Earnings Report
PDF Epioxa is GKOS' next-generation corneal cross-linking iLink therapy for the treatment of keratoconus, a progressive, sight-threatening corneal disease. The NDA submiss [Read more]